Literature DB >> 7515853

Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions.

U Förstermann1, E I Closs, J S Pollock, M Nakane, P Schwarz, I Gath, H Kleinert.   

Abstract

Three isozymes of nitric oxide (NO) synthase (EC 1.14.13.39) have been identified and the cDNAs for these enzymes isolated. In humans, isozymes I (in neuronal and epithelial cells), II (in cytokine-induced cells), and III (in endothelial cells) are encoded for by three different genes located on chromosomes 12, 17, and 7, respectively. The deduced amino acid sequences of the human isozymes show less than 59% identity. Across species, amino acid sequences for each isoform are well conserved (> 90% for isoforms I and III, > 80% for isoform II). All isoforms use L-arginine and molecular oxygen as substrates and require the cofactors NADPH, 6(R)-5,6,7,8-tetrahydrobiopterin, flavin adenine dinucleotide, and flavin mononucleotide. They all bind calmodulin and contain heme. Isoform I is constitutively present in central and peripheral neuronal cells and certain epithelial cells. Its activity is regulated by Ca2+ and calmodulin. Its functions include long-term regulation of synaptic transmission in the central nervous system, central regulation of blood pressure, smooth muscle relaxation, and vasodilation via peripheral nitrergic nerves. It has also been implicated in neuronal death in cerebrovascular stroke. Expression of isoform II of NO synthase can be induced with lipopolysaccharide and cytokines in a multitude of different cells. Based on sequencing data there is no evidence for more than one inducible isozyme at this time. NO synthase II is not regulated by Ca2+; it produces large amounts of NO that has cytostatic effects on parasitic target cells by inhibiting iron-containing enzymes and causing DNA fragmentation. Induced NO synthase II is involved in the pathophysiology of autoimmune diseases and septic shock. Isoform III of NO synthase has been found mostly in endothelial cells. It is constitutively expressed, but expression can be enhanced, eg, by shear stress. Its activity is regulated by Ca2+ and calmodulin. NO from endothelial cells keeps blood vessels dilated, prevents the adhesion of platelets and white cells, and probably inhibits vascular smooth muscle proliferation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515853     DOI: 10.1161/01.hyp.23.6.1121

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  170 in total

1.  Nitric oxide synthase 3 contributes to ventilator-induced lung injury.

Authors:  Katerina Vaporidi; Roland C Francis; Kenneth D Bloch; Warren M Zapol
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-05-07       Impact factor: 5.464

2.  Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro.

Authors:  A Papapetropoulos; K M Desai; R D Rudic; B Mayer; R Zhang; M P Ruiz-Torres; G García-Cardeña; J A Madri; W C Sessa
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 3.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 4.  Vasodilatory mechanisms of beta receptor blockade.

Authors:  Géraldine Rath; Jean-Luc Balligand; Chantal Dessy; Dessy Chantal
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

5.  Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels.

Authors:  Janet R Manning; Gregory Carpenter; Darius R Porter; Stacey L House; Daniel A Pietras; Thomas Doetschman; Jo el J Schultz
Journal:  Growth Factors       Date:  2012-02-06       Impact factor: 2.511

6.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

7.  Difference in protective effects of GIP and GLP-1 on endothelial cells according to cyclic adenosine monophosphate response.

Authors:  Dong-Mee Lim; Keun-Young Park; Won-Min Hwang; Ju-Young Kim; Byung-Joon Kim
Journal:  Exp Ther Med       Date:  2017-03-29       Impact factor: 2.447

8.  Nitric oxide synthase activity is inducible in rat, but not rabbit alveolar macrophages, with a concomitant reduction in arginase activity.

Authors:  C Hey; I Wessler; K Racké
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-06       Impact factor: 3.000

9.  Management of oxidative stress in the CNS: the many roles of glutathione.

Authors:  B H Juurlink
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

Review 10.  Methylene blue for distributive shock: a potential new use of an old antidote.

Authors:  David H Jang; Lewis S Nelson; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.